Legal & General Group
CELU icon

Legal & General Group’s Celularity CELU Stock Holding History

Legal & General Group’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-799
Closed -$4.95K – 3430
2023
Q1 		$4.95K Sell
799
-1,227
-61% -$9.88K ﹤0.01% 3304
2022
Q4 		$26.1K Buy
2,026
+541
+36% +$9.97K ﹤0.01% 3097
2022
Q3 		$34K Buy
1,485
+626
+73% +$19K ﹤0.01% 3063
2022
Q2 		$29K Buy
+859
New +$69.8K ﹤0.01% 3120

Other funds holding CELU

SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
CVSC
C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Legal & General Group's CELU Position: Q2 2023 in Review

Legal & General Group sold out of Celularity (CELU) in Q2 2023, closing a stake of 799 shares — an estimated $4.95K sold.

Legal & General Group first reported a position in CELU in Q2 2022 and held it in 4 quarters. The position peaked at $34K in Q3 2022. 56 funds tracked by Wall St. Rank hold CELU as of Q2 2023.

  • Legal & General Group reported no remaining Celularity position as of Q2 2023 after selling out during the quarter.
  • Legal & General Group sold 799 Celularity shares in Q2 2023, an estimated $4.95K.
  • Legal & General Group first reported a position in Celularity in Q2 2022 and held it in 4 quarters.
  • Legal & General Group's Celularity position peaked at $34K in Q3 2022.
  • 56 funds tracked by Wall St. Rank held Celularity as of Q2 2023.

Based on Legal & General Group's 13F filing for Q2 2023, filed 14 Aug 2023.